SEC Form 4 · accession 0001013606-16-000212
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Christopher G. Chavez
Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 12:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Feb 29, 2016 | J | 285,280 | $0.00 | A | 312,234 | D | |
| Common SharesF1 | Feb 29, 2016 | J | 65,640 | $0.00 | A | 65,640 | I | Christopher G. Chavez Trustee of the Diana J Chavez Irrevocable Trust |
| Common SharesF1 | Feb 29, 2016 | J | 65,640 | $0.00 | A | 65,640 | I | Diana J Chavez of the Trustee of the Christopher G. Chavez Family Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued relate to the exchange of TriVascular, Inc shares for Endologix, Inc shares per Endologix, Inc's agreement to acquire TriVascular, Inc.